Insider Trading activities of Bluebird Bio, Inc. (BLUE)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bluebird Bio, Inc. (BLUE) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bluebird Bio, Inc. since year 2005. Table 2 shows the detailed insider transactions of Bluebird Bio, Inc. since 2005. The reporting company's ticker symbol is BLUE. The reporting company's CIK number is 1293971.
The total value of stock buying since 2005 is $900,936.
The total value of stock sales since 2005 is $293,070,710.
The total value of stock option exercises since 2005 is $15,435,141.


 1   2   3   4 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Bluebird Bio, Inc. (BLUE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-04 0 $0 9,660 $1,538,506 9,160 $153,656
2019-03 0 $0 11,311 $1,697,797 10,811 $383,735
2019-02 0 $0 14,717 $2,084,990 13,958 $530,927
2019-01 0 $0 34,160 $3,838,013 14,635 $374,185
2018-12 0 $0 13,003 $1,467,672 8,600 $74,306
2018-11 0 $0 6,800 $907,796 6,300 $109,471
2018-10 0 $0 8,300 $1,154,302 7,800 $146,176
2018-09 0 $0 11,300 $1,840,166 9,800 $157,176
2018-08 0 $0 52,059 $8,419,753 55,738 $560,679
2018-07 0 $0 8,126 $1,414,995 3,000 $16,500
2018-06 0 $0 27,401 $5,174,290 22,500 $793,405
2018-05 0 $0 16,750 $2,939,847 13,000 $318,110
2018-04 0 $0 27,250 $4,597,384 26,250 $674,887
2018-03 0 $0 10,000 $2,096,536 10,000 $204,820
2018-02 0 $0 7,294 $1,481,602 6,294 $156,807
2018-01 0 $0 65,370 $12,445,924 48,244 $1,681,595
2017-12 0 $0 141,932 $26,683,691 59,023 $718,511
2017-11 0 $0 53,277 $8,009,903 52,277 $395,126
2017-10 0 $0 29,023 $4,055,279 10,150 $112,087
2017-09 0 $0 66,518 $8,598,816 49,382 $413,343
2017-08 0 $0 87,950 $9,797,700 35,950 $230,302
2017-07 0 $0 15,263 $1,595,896 17,456 $338,847
2017-06 0 $0 75,590 $7,890,592 45,986 $987,948
2017-05 0 $0 7,750 $670,055 7,000 $55,199
2017-04 0 $0 7,250 $646,368 11,000 $103,890
2017-03 0 $0 43,185 $3,903,048 42,774 $495,201
2017-02 0 $0 14,723 $1,169,021 10,000 $171,288
2017-01 0 $0 25,810 $1,823,876 20,000 $293,216
2016-10 0 $0 416 $27,870 416 $9,395
2016-09 0 $0 416 $24,544 416 $9,395
2016-08 0 $0 416 $24,544 416 $9,395
2016-07 0 $0 6,719 $332,095 3,912 $67,857
2016-06 0 $0 3,931 $155,945 20,826 $77,290
2016-05 0 $0 1,000 $38,729 1,000 $2,090
2016-04 0 $0 1,000 $49,630 1,000 $2,090
2016-03 0 $0 1,000 $46,366 1,000 $2,090
2016-02 0 $0 1,000 $45,176 1,000 $2,090
2016-01 0 $0 1,000 $44,392 1,000 $2,090
2015-12 9,682 $501,062 1,416 $92,297 72,574 $326,578
2015-11 0 $0 2,416 $174,677 2,416 $13,575
2015-10 0 $0 21,416 $1,905,528 21,416 $155,473
2015-09 0 $0 150,416 $20,189,663 150,416 $856,510
2015-08 0 $0 171,416 $24,507,739 171,416 $578,306
2015-07 0 $0 19,542 $3,133,580 18,416 $149,215
2015-06 0 $0 30,416 $5,677,588 30,416 $448,675
2015-05 0 $0 67,416 $10,523,276 67,416 $461,230
2015-04 0 $0 85,998 $10,500,314 85,998 $292,148
2015-03 0 $0 24,500 $2,669,933 24,500 $255,605
2015-02 0 $0 14,500 $1,283,044 14,500 $30,289
2015-01 0 $0 48,250 $4,493,426 48,250 $160,522
2014-12 3,528 $299,880 86,751 $5,235,273 79,500 $145,562
2014-11 0 $0 35,500 $1,478,228 10,500 $21,932
2014-10 0 $0 318,423 $11,298,711 45,018 $94,086
2014-09 0 $0 318,595 $11,672,957 28,500 $39,044
2014-08 0 $0 20,800 $718,791 10,500 $21,944
2014-07 2,941 $99,994 32,783 $1,255,780 10,500 $21,944
2014-06 0 $0 93,500 $3,358,237 28,500 $39,045
2014-05 0 $0 15,000 $294,980 126,266 $263,895
2014-04 0 $0 15,000 $332,399 10,000 $20,900
2014-03 0 $0 29,500 $737,365 24,500 $42,085
2014-02 0 $0 24,000 $512,944 19,000 $39,709
2014-01 0 $0 1,837,500 $41,568,121 38,500 $69,065
2013-12 0 $0 35,000 $722,750 35,000 $52,629

Table 2. Detailed insider stock purchases, sales, and option exercises of Bluebird Bio, Inc. insiders (BLUE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-04-10 Walsh Jeffrey T. (Chief Strategy Officer) Sale 1,500 156.83 235,251
2019-04-10 Walsh Jeffrey T. (Chief Strategy Officer) Option Ex 1,500 24.47 36,705
2019-04-05 Gregory Philip D (Chief Scientific Officer) Sale 1,800 157.72 283,894
2019-04-05 Gregory Philip D (Chief Scientific Officer) Option Ex 1,300 63.05 81,971
2019-04-04 Davidson David (Chief Medical Officer) Sale 6,360 160.28 1,019,361
2019-04-04 Davidson David (Chief Medical Officer) Option Ex 6,360 5.50 34,980
2019-03-13 Davidson David (Chief Medical Officer) Sale 3,101 146.45 454,153
2019-03-13 Davidson David (Chief Medical Officer) Option Ex 3,101 5.50 17,055
2019-03-11 Walsh Jeffrey T. (Chief Strategy Officer) Sale 1,500 139.80 209,698
2019-03-11 Walsh Jeffrey T. (Chief Strategy Officer) Option Ex 1,500 24.47 36,705
2019-03-05 Gregory Philip D (Chief Scientific Officer) Sale 1,800 147.78 265,998
2019-03-05 Gregory Philip D (Chief Scientific Officer) Option Ex 1,300 63.05 81,971
2019-03-04 Davidson David (Chief Medical Officer) Sale 4,910 156.41 767,948
2019-03-04 Davidson David (Chief Medical Officer) Option Ex 4,910 50.51 248,004
2019-02-28 Wentworth Kory James (Principal Accounting Officer) Sale 51 151.71 7,737
2019-02-25 Wentworth Kory James (Principal Accounting Officer) Sale 208 150.00 31,200
2019-02-25 Cole Jason (Chief Operating and) Sale 6,248 150.77 942,023
2019-02-25 Cole Jason (Chief Operating and) Option Ex 6,248 36.52 228,176
2019-02-08 Walsh Jeffrey T. (Chief Financial and) Sale 1,500 131.43 197,145
2019-02-08 Walsh Jeffrey T. (Chief Financial and) Option Ex 1,500 24.47 36,705
2019-02-05 Gregory Philip D (Chief Scientific Officer) Sale 1,800 137.89 248,209
2019-02-05 Gregory Philip D (Chief Scientific Officer) Option Ex 1,300 63.05 81,971
2019-02-04 Davidson David (Chief Medical Officer) Sale 4,910 134.15 658,676
2019-02-04 Davidson David (Chief Medical Officer) Option Ex 4,910 37.49 184,075
2019-01-28 Wentworth Kory James (Principal Accounting Officer) Sale 209 125.96 26,326
2019-01-18 Davidson David (Chief Medical Officer) Sale 2,035 130.05 264,643
2019-01-18 Davidson David (Chief Medical Officer) Option Ex 2,035 24.47 49,796
2019-01-16 Walsh Jeffrey T. (Chief Financial) Sale 3,000 125.14 375,429
2019-01-16 Walsh Jeffrey T. (Chief Financial) Option Ex 3,000 24.47 73,410
2019-01-16 Gregory Philip D (Chief Scientific Officer) Sale 1,900 124.25 236,069
2019-01-16 Gregory Philip D (Chief Scientific Officer) Option Ex 1,400 75.60 105,839
2019-01-07 Finger Alison Cecily (Chief Commercial Officer) Sale 643 113.80 73,171
2019-01-07 Davidson David (Chief Medical Officer) Sale 2,664 113.80 303,157
2019-01-07 Leschly Nick (President and CEO) Sale 7,374 113.80 839,146
2019-01-07 Walsh Jeffrey T. (Chief Financial) Sale 3,012 113.80 342,756
2019-01-07 Cole Jason (Chief Legal Officer) Sale 1,416 113.80 161,137
2019-01-07 Gregory Philip D (Chief Scientific Officer) Sale 3,879 110.84 429,936
2019-01-07 Gregory Philip D (Chief Scientific Officer) Option Ex 600 50.51 30,306
2019-01-03 Finger Alison Cecily (Chief Commercial Officer) Sale 428 99.30 42,501
2019-01-03 Davidson David (Chief Medical Officer) Sale 100 100.32 10,032
2019-01-03 Davidson David (Chief Medical Officer) Option Ex 100 24.47 2,447
2019-01-02 Davidson David (Chief Medical Officer) Sale 7,500 97.83 733,710
2019-01-02 Davidson David (Chief Medical Officer) Option Ex 7,500 14.98 112,387
2018-12-19 Wentworth Kory James (Principal Accounting Officer) Sale 388 103.05 39,983
2018-12-06 High Susanna Gatti (Chief Operating Officer) Sale 1,875 105.65 198,093
2018-12-06 Gregory Philip D (Chief Scientific Officer) Sale 850 107.07 91,006
2018-12-06 Gregory Philip D (Chief Scientific Officer) Option Ex 600 50.51 30,306
2018-12-04 Davidson David (Chief Medical Officer) Sale 2,000 120.96 241,916
2018-12-04 Davidson David (Chief Medical Officer) Option Ex 2,000 5.50 11,000
2018-12-03 High Susanna Gatti (Chief Operating Officer) Sale 1,890 113.83 215,134
2018-12-03 Davidson David (Chief Medical Officer) Sale 6,000 113.59 681,540
2018-12-03 Davidson David (Chief Medical Officer) Option Ex 6,000 5.50 33,000
2018-11-05 Gregory Philip D (Chief Scientific Officer) Sale 1,800 137.49 247,476
2018-11-05 Gregory Philip D (Chief Scientific Officer) Option Ex 1,300 63.05 81,971
2018-11-02 Davidson David (Chief Medical Officer) Sale 5,000 132.06 660,320
2018-11-02 Davidson David (Chief Medical Officer) Option Ex 5,000 5.50 27,500
2018-10-10 Walsh Jeffrey T. (Chief Financial) Sale 1,500 135.83 203,739
2018-10-10 Walsh Jeffrey T. (Chief Financial) Option Ex 1,500 24.47 36,705
2018-10-05 Gregory Philip D (Chief Scientific Officer) Sale 1,800 140.30 252,543
2018-10-05 Gregory Philip D (Chief Scientific Officer) Option Ex 1,300 63.05 81,971
2018-10-02 Davidson David (Chief Medical Officer) Sale 5,000 139.60 698,020
2018-10-02 Davidson David (Chief Medical Officer) Option Ex 5,000 5.50 27,500
2018-09-10 Mandell James (Director) Sale 1,000 151.09 151,093
2018-09-10 Walsh Jeffrey T. (Chief Financial) Sale 1,500 150.34 225,511
2018-09-10 Walsh Jeffrey T. (Chief Financial) Option Ex 1,500 24.47 36,705
2018-09-05 Gregory Philip D (Chief Scientific Officer) Sale 1,800 164.06 295,304
2018-09-05 Gregory Philip D (Chief Scientific Officer) Option Ex 1,300 63.05 81,971
2018-09-04 Davidson David (Chief Medical Officer) Sale 7,000 166.89 1,168,258
2018-09-04 Davidson David (Chief Medical Officer) Option Ex 7,000 5.50 38,500
2018-08-30 Walsh Jeffrey T. (Chief Financial) Sale 20,000 175.70 3,513,920
2018-08-30 Walsh Jeffrey T. (Chief Financial) Option Ex 20,000 10.69 213,720
2018-08-20 Finger Alison Cecily (Chief Commercial Officer) Sale 259 158.07 40,941
2018-08-10 Walsh Jeffrey T. (Chief Financial) Sale 1,500 157.12 235,672
2018-08-10 Walsh Jeffrey T. (Chief Financial) Option Ex 1,500 5.50 8,250
2018-08-08 Cole Jason (Chief Legal Officer) Option Ex 4,438 22.53 99,988
2018-08-06 Gregory Philip D (Chief Scientific Officer) Sale 1,800 156.91 282,432
2018-08-06 Gregory Philip D (Chief Scientific Officer) Option Ex 1,300 63.05 81,971
2018-08-02 Davidson David (Chief Medical Officer) Sale 7,000 151.16 1,058,148
2018-08-02 Davidson David (Chief Medical Officer) Option Ex 7,000 5.50 38,500
2018-08-02 Walsh Jeffrey T. (Chief Financial) Sale 21,500 152.96 3,288,640
2018-08-02 Walsh Jeffrey T. (Chief Financial) Option Ex 21,500 5.50 118,250
2018-07-11 Davidson David (Chief Medical Officer) Sale 3,000 180.15 540,444
2018-07-11 Davidson David (Chief Medical Officer) Option Ex 3,000 5.50 16,500
2018-07-09 Cole Jason (Chief Legal Officer) Sale 5,126 170.61 874,551
2018-06-18 Gregory Philip D (Chief Scientific Officer) Sale 3,901 178.10 694,775
2018-06-14 Vachon Mark (Director) Sale 1,000 190.10 190,104
2018-06-04 High Susanna Gatti (Chief Operating Officer) Sale 3,500 199.11 696,892
2018-06-04 High Susanna Gatti (Chief Operating Officer) Option Ex 3,500 68.65 240,275
2018-06-04 Vachon Mark (Director) Sale 6,000 189.17 1,135,038
2018-06-04 Vachon Mark (Director) Option Ex 6,000 39.17 235,020
2018-06-04 Davidson David (Chief Medical Officer) Sale 13,000 189.04 2,457,481
2018-06-04 Davidson David (Chief Medical Officer) Option Ex 13,000 24.47 318,110
2018-05-04 Cole Jason (Chief Legal Officer) Sale 3,750 170.23 638,366
2018-05-02 Davidson David (Chief Medical Officer) Sale 13,000 177.04 2,301,481
2018-05-02 Davidson David (Chief Medical Officer) Option Ex 13,000 24.47 318,110
2018-04-12 Davidson David (Chief Medical Officer) Sale 3,000 180.17 540,507
2018-04-12 Davidson David (Chief Medical Officer) Option Ex 3,000 24.47 73,410
2018-04-02 Davidson David (Chief Medical Officer) Sale 22,000 167.11 3,676,508
2018-04-02 Davidson David (Chief Medical Officer) Option Ex 22,000 24.47 538,340
2018-04-02 Gregory Philip D (Chief Scientific Officer) Sale 2,250 169.05 380,369
2018-04-02 Gregory Philip D (Chief Scientific Officer) Option Ex 1,250 50.51 63,137
2018-03-15 Vachon Mark (Director) Sale 6,000 215.07 1,290,408
2018-03-15 Vachon Mark (Director) Option Ex 6,000 30.47 182,820
2018-03-02 Davidson David (Chief Medical Officer) Sale 4,000 201.53 806,128
2018-03-02 Davidson David (Chief Medical Officer) Option Ex 4,000 5.50 22,000
2018-02-28 High Susanna Gatti (Chief Operating Officer) Sale 1,044 202.57 211,478
2018-02-28 High Susanna Gatti (Chief Operating Officer) Option Ex 1,044 68.65 71,670
2018-02-02 Davidson David (Chief Medical Officer) Sale 4,000 202.56 810,220
2018-02-02 Davidson David (Chief Medical Officer) Option Ex 4,000 5.50 22,000
2018-02-01 Gregory Philip D (Chief Scientific Officer) Sale 2,250 204.40 459,904
2018-02-01 Gregory Philip D (Chief Scientific Officer) Option Ex 1,250 50.51 63,137
2018-01-30 High Susanna Gatti (Chief Operating Officer) Sale 17,262 198.11 3,419,792
2018-01-30 High Susanna Gatti (Chief Operating Officer) Option Ex 14,794 68.65 1,015,608
2018-01-30 Cole Jason (Chief Legal Officer) Sale 25,000 198.11 4,952,750
2018-01-30 Cole Jason (Chief Legal Officer) Option Ex 25,000 22.53 563,250
2018-01-08 Davidson David (Chief Medical Officer) Sale 1,200 173.01 207,609
2018-01-08 Davidson David (Chief Medical Officer) Option Ex 1,200 5.50 6,600
2018-01-05 Davidson David (Chief Medical Officer) Sale 2,322 173.71 403,361
2018-01-05 Leschly Nick (President and CEO) Sale 5,435 173.71 944,130
2018-01-05 Walsh Jeffrey T. (Chief Financial) Sale 3,060 173.71 531,561
2018-01-05 Cole Jason (Chief Legal Officer) Sale 1,129 173.72 196,124
2018-01-05 Gregory Philip D (Chief Scientific Officer) Sale 1,712 173.71 297,398
2018-01-03 Davidson David (Chief Medical Officer) Sale 6,000 181.00 1,086,006
2018-01-03 Davidson David (Chief Medical Officer) Option Ex 6,000 5.50 33,000
2018-01-03 Gregory Philip D (Chief Scientific Officer) Sale 2,250 180.97 407,193
2018-01-03 Gregory Philip D (Chief Scientific Officer) Option Ex 1,250 50.51 63,137
2017-12-13 Leschly Nick (President and CEO) Sale 117,500 185.03 21,740,907
2017-12-13 Leschly Nick (President and CEO) Option Ex 37,873 5.50 208,301
2017-12-11 Vachon Mark (Director) Sale 7,000 215.03 1,505,210
2017-12-11 Vachon Mark (Director) Option Ex 6,000 30.47 182,820
2017-12-11 Walsh Jeffrey T. (Chief Financial) Sale 9,900 215.92 2,137,588
2017-12-11 Walsh Jeffrey T. (Chief Financial) Option Ex 9,900 24.47 242,253
2017-12-01 High Susanna Gatti (Chief Operating Officer) Sale 1,282 172.15 220,696
2017-12-01 Davidson David (Chief Medical Officer) Sale 4,000 172.65 690,616
2017-12-01 Davidson David (Chief Medical Officer) Option Ex 4,000 5.50 22,000
2017-12-01 Gregory Philip D (Chief Scientific Officer) Sale 2,250 172.74 388,674
2017-12-01 Gregory Philip D (Chief Scientific Officer) Option Ex 1,250 50.51 63,137
2017-11-10 Walsh Jeffrey T. (Chief Financial) Sale 9,900 149.56 1,480,624
2017-11-10 Walsh Jeffrey T. (Chief Financial) Option Ex 9,900 10.69 105,791
2017-11-01 Davidson David (Chief Medical Officer) Sale 4,000 145.32 581,276
2017-11-01 Davidson David (Chief Medical Officer) Option Ex 4,000 5.50 22,000
2017-11-01 Leschly Nick (President and CEO) Sale 2,127 145.17 308,778
2017-11-01 Leschly Nick (President and CEO) Option Ex 2,127 5.50 11,698
2017-11-01 Walsh Jeffrey T. (Chief Financial) Sale 35,000 151.83 5,313,945
2017-11-01 Walsh Jeffrey T. (Chief Financial) Option Ex 35,000 5.50 192,500
2017-11-01 Gregory Philip D (Chief Scientific Officer) Sale 2,250 144.57 325,280
2017-11-01 Gregory Philip D (Chief Scientific Officer) Option Ex 1,250 50.51 63,137
2017-10-23 Leschly Nick (President and CEO) Sale 3,700 145.26 537,454
2017-10-20 Leschly Nick (President and CEO) Sale 3,350 145.02 485,813
2017-10-17 Leschly Nick (President and CEO) Sale 10,823 145.05 1,569,843
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of BLUE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bluebird Bio, Inc. (symbol BLUE, CIK number 1293971) see the Securities and Exchange Commission (SEC) website.